Evidence map›Paper›PMID 40201031›Full record

ArticleJournal of mental health research in intellectual disabilities2025

Experiences with Take it Personal!+ from People with Mild Intellectual Disability or Borderline Intellectual Functioning and Substance Use Disorder and Their Confidants: A Qualitative Study.

Lotte C F Gosens, Robert Didden, Jannet M de Jonge, Arnt F A Schellekens, Joanneke E L VanDerNagel, Roy Otten, Evelien A P Poelen

Abstract read
In one paragraph

Article in Journal of mental health research in intellectual disabilities, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lotte C F GosensResearch & Development, Pluryn.
Robert DiddenBehavioural Science Institute, Radboud University.
Jannet M de JongeACHIEVE, Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences.
Arnt F A SchellekensDepartment of Psychiatry, Radboudumc.
Joanneke E L VanDerNagelNijmegen Institute for Scientist-Practitioners in Addiction, Radboud University.
Roy OttenBehavioural Science Institute, Radboud University.
Evelien A P PoelenResearch & Development, Pluryn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Take it Personal!+ is a treatment program for individuals with Mild Intellectual Disability or Borderline Intellectual Functioning (MID-BIF) and Substance Use Disorder (SUD). It is supported by a mobile health application (mHealth), and researchers found it can reduce Substance Use (SU). Aims: This study aimed to explore the usability of the treatment program in as experienced by clients and their confidants. Methods: We conducted post-treatment, semi-structured interviews with clients ( Results: Overall clients and confidants experienced the treatment program as usable, and most mentioned the program helped to reduce SU. The clients and confidants reported the presence of a confidant was helpful. Some clients and confidants reported the mHealth application was helpful. Components that were perceived as effective were self-control skills, daily registration exercise and discussing quantity of SU non-judgingly. Perceived impeding factors were video calling and a non-supportive network. Conclusion: This study shows that Take it Personal!+ is an useable treatment program for individuals with MID-BIF and SUD, that helps to decrease their self-reported SU. Nevertheless, there is room for improvement for further adapting the treatment, which will be discussed.

Indexed as

cognitive behavioral therapyintellectual disabilitiesMotivational interviewingqualitative studysubstance use disorder

Identifiers

PMID40201031
PMCPMC11974916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.